Bedel Financial Consulting’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,210
| Closed | -$15K | – | 249 |
|
|
2022
Q1 | $15K | Hold |
1,210
| – | – | ﹤0.01% | 590 |
|
|
2021
Q4 | $21K | Hold |
1,210
| – | – | 0.01% | 552 |
|
|
2021
Q3 | $22K | Hold |
1,210
| – | – | 0.01% | 531 |
|
|
2021
Q2 | $28K | Hold |
1,210
| – | – | 0.01% | 487 |
|
|
2021
Q1 | $18K | Hold |
1,210
| – | – | 0.01% | 527 |
|
|
2020
Q4 | $7K | Hold |
1,210
| – | – | ﹤0.01% | 603 |
|
|
2020
Q3 | $6K | Hold |
1,210
| – | – | ﹤0.01% | 581 |
|
|
2020
Q2 | $6K | Hold |
1,210
| – | – | ﹤0.01% | 551 |
|
|
2020
Q1 | $4K | Hold |
1,210
| – | – | ﹤0.01% | 593 |
|
|
2019
Q4 | $3K | Hold |
1,210
| – | – | ﹤0.01% | 625 |
|
|
2019
Q3 | $4K | Hold |
1,210
| – | – | ﹤0.01% | 585 |
|
|
2019
Q2 | $4K | Hold |
1,210
| – | – | ﹤0.01% | 587 |
|
|
2019
Q1 | $4K | Hold |
1,210
| – | – | ﹤0.01% | 589 |
|
|
2018
Q4 | $2K | Hold |
1,210
| – | – | ﹤0.01% | 601 |
|
|
2018
Q3 | $3K | Hold |
1,210
| – | – | ﹤0.01% | 586 |
|
|
2018
Q2 | $3K | Hold |
1,210
| – | – | ﹤0.01% | 587 |
|
|
2018
Q1 | $3K | Buy |
+1,210
| New | +$3K | ﹤0.01% | 586 |
|